Search

Your search keyword '"Wojdyla, Daniel"' showing total 1,101 results

Search Constraints

Start Over You searched for: Author "Wojdyla, Daniel" Remove constraint Author: "Wojdyla, Daniel"
1,101 results on '"Wojdyla, Daniel"'

Search Results

106. Apixaban or Warfarin and Aspirin or Placebo After Acute Coronary Syndrome or Percutaneous Coronary Intervention in Patients With Atrial Fibrillation and Prior Stroke

110. LB-469807-04 EFFICACY AND SAFETY OF APIXABAN VERSUS ASPIRIN ACCORDING TO CHA2DS2-VASC SCORE IN PATIENTS WITH SUBCLINICAL ATRIAL FIBRILLATION IN ARTESIA

111. Duration of Anticoagulation Interruption Before Invasive Procedures and Outcomes in Patients With Atrial Fibrillation : Insights From the ARISTOTLE Trial

112. Outcomes After Acute Coronary Syndrome in Patients With Diabetes Mellitus and Peripheral Artery Disease (from the TRACER, TRILOGY-ACS, APPRAISE-2, and PLATO Clinical Trials).

113. Anemia is associated with bleeding and mortality, but not stroke, in patients with atrial fibrillation: Insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial

116. Anxiety, Depression, and Quality of Life After Procedural Intervention for Uterine Fibroids

117. Impact of prior oral anticoagulant use and outcomes on patients from secondary analysis in the AUGUSTUS trial

122. Maternal and Neonatal Individual Risks and Benefits Associated with Caesarean Delivery: Multicentre Prospective Study

124. Efficacy and Safety of Antithrombotic Therapy in Patients With Atrial Fibrillation, Recent Acute Coronary Syndrome, or Percutaneous Coronary Intervention and a History of Heart Failure: Insights From the AUGUSTUS Trial

125. Abstract 12512: Antithrombotic Strategies According to Age in Patients With Atrial Fibrillation and a Recent Acute Coronary Syndrome or Percutaneous Coronary Intervention: Insights From the Augustus Trial

126. Abstract 10426: Worse Clinical Outcomes in Patients with Acute Coronary Syndrome and Prior or New Onset Heart Failure: Insights from 47,474 Patients in a Pooled Analysis of Randomized Clinical Trials

127. Abstract 9290: Relationship Between Body Weight and Pharmacokinetics of Apixaban in Patients With Atrial Fibrillation: Insights from the ARISTOTLE Trial

128. TCT-167 Utilization Rates and In-Hospital Outcomes Associated With Intravascular Imaging–Guided PCI in the USA: An Analysis of the NCDR CathPCI Registry

129. 1001 Longitudinal changes in type 2 SLE activity

132. A 3-year multicentre randomized controlled trial of etonogestrel- and levonorgestrel-releasing contraceptive implants, with non-randomized matched copper-intrauterine device controls

134. Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study

136. The number of flares patients experience impacts on damage accrual in systemic lupus erythematosus: data from a multiethnic Latin American cohort

137. Clinical outcomes and management associated with major bleeding in patients with atrial fibrillation treated with apixaban or warfarin: insights from the ARISTOTLE trial

140. EFFECT OF APIXABAN VERSUS VITAMIN K ANTAGONIST AND ASPIRIN VERSUS PLACEBO ON DAYS ALIVE AND OUT OF HOSPITAL IN THE AUGUSTUS RANDOMIZED CONTROLLED TRIAL

141. NATIONWIDE TRENDS AND OUTCOMES OF PERCUTANEOUS CORONARY INTERVENTIONS FOLLOWING DIAGNOSTIC ANGIOGRAPHY PERFORMED BY NON-INTERVENTIONAL CARDIOLOGIST VERSUS INTERVENTIONALISTS: INSIGHTS FROM THE CATHPCI REGISTRY

142. Contribuciones de la estadística en tiempos de pandemia

143. Apixaban or Vitamin K Antagonists and Aspirin or Placebo According to Kidney Function in Patients With Atrial Fibrillation After Acute Coronary Syndrome or Percutaneous Coronary Intervention : Insights From the AUGUSTUS Trial

144. Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Left Ventricular Hypertrophy : Insights From the ARISTOTLE Trial

145. Premature permanent discontinuation of apixaban or warfarin in patients with atrial fibrillation

146. Maternal near miss and maternal death in the World Health Organization's 2005 global survey on maternal and perinatal health/Deces maternels et deces maternels evites de justesse dans le cadre de l'enquete mondiale sur la sante maternelle et perinatale realisee en 2005 par l'Organisation mondiale de la Sante/Cuasieventos maternos y mortalidad materna en la encuesta mundial 2005 de la Organizacion Mundial

147. The worldwide incidence of preterm birth: a systematic review of maternal mortality and morbidity/Incidence mondiale de la missance avant terme: revue sytemtique de la mortalite et de la morbidite maternelle/Incidencia mundial de parto prematuro: revision sistematica de la morbilidad y mortalidad maternas

148. Efficacy and Safety of Apixaban Compared with Warfarin for Stroke Prevention in Patients with Atrial Fibrillation from East Asia: A Subanalysis of the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial

149. The efficacy of ticagrelor is maintained in women with acute coronary syndromes participating in the prospective, randomized, PLATelet inhibition and patient Outcomes (PLATO) trial

150. Apixaban vs. warfarin with concomitant aspirin in patients with atrial fibrillation: insights from the ARISTOTLE trial

Catalog

Books, media, physical & digital resources